Back to Search
FATIH UCKUN, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1891978391Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
36852(MN)
Research & Publications (20)
Anti-retroviral activity of GMP-grade stampidine against genotypically and phenotypically nucleoside reverse transcriptase inhibitor resistant recombinant human immunodeficiency virus. An in vitro study.
PMID 17396622·Arzneimittelforschung·2007
8-other
Chemosensitizing anti-cancer activity of LFM-A13, a leflunomide metabolite analog targeting polo-like kinases.
PMID 18073537·Cell Cycle·2007
7-preclinical
Bruton's tyrosine kinase prevents activation of the anti-apoptotic transcription factor STAT3 and promotes apoptosis in neoplastic B-cells and B-cell precursors exposed to oxidative stress.
PMID 17367410·Br J Haematol·2007
7-preclinical
Potency of stampidine against multi-nucleoside reverse transcriptase inhibitor resistant human immunodeficiency viruses.
PMID 16570827·Arzneimittelforschung·2006
8-other
Stampidine as a novel nucleoside reverse transcriptase inhibit with potent anti-HIV activity.
PMID 16570821·Arzneimittelforschung·2006
6-review
Unmet challenges in HIV therapy and potential of stampidine.
PMID 16570820·Arzneimittelforschung·2006
6-review
Vinorelbine-based salvage chemotherapy for therapy-refractory aggressive leukaemias.
PMID 17061978·Br J Haematol·2006
3-trial
In vivo pharmacokinetics and toxicity profile of the anti-HIV agent stampidine in dogs and feline immunodeficiency virus-infected cats.
PMID 16570826·Arzneimittelforschung·2006
4-observational
Stampidine is a potent inhibitor of Zidovudine- and nucleoside analog reverse transcriptase inhibitor-resistant primary clinical human immunodeficiency virus type 1 isolates with thymidine analog mutations.
PMID 12384373·Antimicrob Agents Chemother·2002
8-other
In vivo toxicity, pharmacokinetics, and anti-human immunodeficiency virus activity of stavudine-5'-(p-bromophenyl methoxyalaninyl phosphate) (stampidine) in mice.
PMID 12384347·Antimicrob Agents Chemother·2002
7-preclinical
Anti-inflammatory activity profile of JANEX-1 in preclinical animal models.
PMID 18024136·Bioorg Med Chem·2008
7-preclinical
Bruton's tyrosine kinase as a new therapeutic target.
PMID 18045057·Anticancer Agents Med Chem·2007
6-review
Anti-breast cancer activity of LFM-A13, a potent inhibitor of Polo-like kinase (PLK).
PMID 17098432·Bioorg Med Chem·2007
7-preclinical
Preclinical toxicity and pharmacokinetics of the Bruton's tyrosine kinase-targeting anti-leukemic drug candidate, alpha-cyano-beta-hydroxy-beta-methyl-N- (2,5-dibromophenyl) propenamide (LFM-A13).
PMID 17341007·Arzneimittelforschung·2007
7-preclinical
Improved oral bioavailability of anti-HIV agent N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea (HI-443) in a novel lipophilic formulation.
PMID 17469651·Arzneimittelforschung·2007
7-preclinical
In vivo pharmacokinetics and toxicity of a novel hydrophilic oral formulation of the potent non-nucleoside reverse transcriptase inhibitor compound N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea (HI-443).
PMID 17515292·Arzneimittelforschung·2007
7-preclinical
N'-[2-(2-thiophene) ethyl]-N'-[2-(5-bromopyridyl)]thiourea (HI-443), a rationally designed non-nucleoside reverse transcriptase inhibitor compound with potent anti-HIV activity.
PMID 17598700·Arzneimittelforschung·2007
8-other
In vivo pharmacokinetics, metabolism, toxicity, and anti-HIV activity of N'-[2-(2-Thiophene)ethyl]-N'-[2-(5-bromopyridyl)]thiourea (HI-443), a potent non-nucleoside inhibitor of HIV reverse transcriptase.
PMID 17803063·Arzneimittelforschung·2007
7-preclinical
Non-receptor tyrosine kinases as molecular targets for patient tailored cancer therapy.
PMID 18045054·Anticancer Agents Med Chem·2007
8-other
Targeting JAK3 tyrosine kinase-linked signal transduction pathways with rationally-designed inhibitors.
PMID 18045056·Anticancer Agents Med Chem·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2848 PATTON RD
ROSEVILLE, MN 55113 - Phone
- (651) 628-0098
Quick Facts
- NPI
- 1891978391
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile